BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hirabayashi K, Zamboni G, Nishi T, Tanaka A, Kajiwara H, Nakamura N. Histopathology of gastrointestinal neuroendocrine neoplasms. Front Oncol 2013;3:2. [PMID: 23346552 DOI: 10.3389/fonc.2013.00002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Anderson KB, Meinkoth J, Hallman M, Bailey K, Brandão J. Cytological Diagnosis of Gastric Neuroendocrine Carcinoma in a Pet Inland Bearded Dragon (Pogona Vitticeps). Journal of Exotic Pet Medicine 2019;29:188-93. [DOI: 10.1053/j.jepm.2018.09.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Yang T, Fong ZV, Pak L, Wang SJ, Wei J, Wang J. A Modified T-stage Classification for Gastric Neuroendocrine Tumors. J Surg Res 2021;270:486-94. [PMID: 34800795 DOI: 10.1016/j.jss.2021.10.002] [Reference Citation Analysis]
3 Zhu J, Xiao W, Li Y. Management of Primary Hepatopancreatobiliary and Ampulla Large Cell Neuroendocrine Carcinoma. J Laparoendosc Adv Surg Tech A 2021. [PMID: 34637632 DOI: 10.1089/lap.2021.0482] [Reference Citation Analysis]
4 Hadano A, Hirabayashi K, Yamada M, Kawanishi A, Takanashi Y, Kawaguchi Y, Nakagohri T, Nakamura N, Mine T. Molecular alterations in sporadic pancreatic neuroendocrine microadenomas. Pancreatology 2016;16:411-5. [PMID: 26905832 DOI: 10.1016/j.pan.2016.01.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
5 Li RK, Zhao J, Rao SX, Chen CZ, Zeng MS, Qiang JW. Primary hepatic neuroendocrine carcinoma: MR imaging findings including preliminary observation on diffusion-weighted imaging. Abdom Imaging. 2013;38:1269-1276. [PMID: 23942951 DOI: 10.1007/s00261-013-0029-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
6 Monteiro de Melo Santos D, López-Tomassetti Fernández E, Sánchez Ramos M, Hernández Hernández JR. Improved survival with palliative surgery and chemotherapy for Mixed adenoneuroendocrine carcinoma of the gastroesophageal junction with liver metastases. Cir Esp (Engl Ed) 2018;96:58-61. [PMID: 28687256 DOI: 10.1016/j.ciresp.2017.03.014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Pirozzolo G, Cona C, Rizzo M, Shala F, Berisha S, Recordare A. Long term recurrence in primary liver neuroendocrine tumor: Report of a single case and review of literature. Ann Hepatobiliary Pancreat Surg 2018;22:159-63. [PMID: 29896578 DOI: 10.14701/ahbps.2018.22.2.159] [Reference Citation Analysis]
8 Han X, Cui Y, Yang C, Sun W, Wu J, Gao Y, Xue H, Li X, Shen L, Peng Y, Zhang H, Hu Y, Zhong L, Chen X, Ge Z. Endoscopic biopsy in gastrointestinal neuroendocrine neoplasms: a retrospective study. PLoS One 2014;9:e103210. [PMID: 25068592 DOI: 10.1371/journal.pone.0103210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Nikas IP, Sepsa A, Kleidaradaki E, Salla C. EUS-FNA Diagnosis of a Metastatic Adult Granulosa Cell Tumor in the Stomach. Lab Med 2022:lmac024. [PMID: 35394548 DOI: 10.1093/labmed/lmac024] [Reference Citation Analysis]
10 Papalampros A, Mpaili E, Moris D, Sarlanis H, Tsoli M, Felekouras E, Trafalis DT, Kontos M. A case report on metastatic ileal neuroendocrine neoplasm to the breast masquerading as primary breast cancer: A diagnostic challenge and management dilemma. Medicine (Baltimore) 2019;98:e14989. [PMID: 31008928 DOI: 10.1097/MD.0000000000014989] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wang Z, Li W, Chen T, Yang J, Luo L, Zhang L, Sun B, Liang R. Retrospective analysis of the clinicopathological characteristics of gastrointestinal neuroendocrine neoplasms. Exp Ther Med. 2015;10:1084-1088. [PMID: 26622444 DOI: 10.3892/etm.2015.2634] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
12 Luque RM, Sampedro-Nuñez M, Gahete MD, Ramos-Levi A, Ibáñez-Costa A, Rivero-Cortés E, Serrano-Somavilla A, Adrados M, Culler MD, Castaño JP, Marazuela M. In1-ghrelin, a splice variant of ghrelin gene, is associated with the evolution and aggressiveness of human neuroendocrine tumors: Evidence from clinical, cellular and molecular parameters. Oncotarget 2015;6:19619-33. [PMID: 26124083 DOI: 10.18632/oncotarget.4316] [Reference Citation Analysis]
13 Celotti A, Pulcini G, Schieppati M, Ministrini S, Berruti A, Ronconi M. An unusual case of a well-differentiated neuroendocrine tumour of the ileum with peritoneal carcinomatosis: a case report. World J Surg Oncol 2015;13:169. [PMID: 25933800 DOI: 10.1186/s12957-015-0585-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Sohda M, Saeki H, Kuwano H, Miyazaki T, Yokobori T, Sano A, Sakai M, Kakeji Y, Toh Y, Doki Y, Matsubara H. Diagnostic Immunostaining and Tumor Markers Predict the Prognosis of Esophageal Neuroendocrine Cell Carcinoma Patients. Ann Surg Oncol 2021. [PMID: 33843025 DOI: 10.1245/s10434-021-09872-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Pinato DJ, Tan TM, Toussi ST, Ramachandran R, Martin N, Meeran K, Ngo N, Dina R, Sharma R. An expression signature of the angiogenic response in gastrointestinal neuroendocrine tumours: correlation with tumour phenotype and survival outcomes. Br J Cancer 2014;110:115-22. [PMID: 24231952 DOI: 10.1038/bjc.2013.682] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
16 Carter AM, Tan C, Pozo K, Telange R, Molinaro R, Guo A, De Rosa E, Martinez JO, Zhang S, Kumar N, Takahashi M, Wiederhold T, Ghayee HK, Oltmann SC, Pacak K, Woltering EA, Hatanpaa KJ, Nwariaku FE, Grubbs EG, Gill AJ, Robinson B, Gillardon F, Reddy S, Jaskula-Sztul R, Mobley JA, Mukhtar MS, Tasciotti E, Chen H, Bibb JA. Phosphoprotein-based biomarkers as predictors for cancer therapy. Proc Natl Acad Sci U S A 2020;117:18401-11. [PMID: 32690709 DOI: 10.1073/pnas.2010103117] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
17 Raiker R, Chauhan A, Hasanein H, Burkeen G, Horn M, Veedu J, Vela C, Arnold S, Kolesar J, Anthony L, Evers BM, Cavnar M. Biliary tract large cell neuroendocrine carcinoma: current evidence. Orphanet J Rare Dis 2019;14:266. [PMID: 31752927 DOI: 10.1186/s13023-019-1230-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
18 Luque RM, Sampedro-Nuñez M, Gahete MD, Ramos-Levi A, Ibáñez-Costa A, Rivero-Cortés E, Serrano-Somavilla A, Adrados M, Culler MD, Castaño JP, Marazuela M. In1-ghrelin, a splice variant of ghrelin gene, is associated with the evolution and aggressiveness of human neuroendocrine tumors: Evidence from clinical, cellular and molecular parameters. Oncotarget 2015;6:19619-33. [PMID: 26124083 DOI: 10.18632/oncotarget.4316] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
19 Gennatas S, Noble J, Stanway S, Gunapala R, Chowdhury R, Wotherspoon A, Benepal T, Popat S. Patterns of relapse in extrapulmonary small cell carcinoma: retrospective analysis of outcomes from two cancer centres. BMJ Open. 2015;5:e006440. [PMID: 25588780 DOI: 10.1136/bmjopen-2014-006440] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
20 Tang LH, Basturk O, Sue JJ, Klimstra DS. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas. Am J Surg Pathol. 2016;40:1192-1202. [PMID: 27259015 DOI: 10.1097/pas.0000000000000662] [Cited by in Crossref: 176] [Cited by in F6Publishing: 78] [Article Influence: 35.2] [Reference Citation Analysis]
21 Duan K, Mete O. Algorithmic approach to neuroendocrine tumors in targeted biopsies: Practical applications of immunohistochemical markers: Duan and Mete. Cancer Cytopathology 2016;124:871-84. [DOI: 10.1002/cncy.21765] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
22 Thompson AA, Suhail FK, Mirchia K, Rawlins SR. A Case of Profound Secretory Diarrhea Revealing 2 Primary Neuroendocrine Tumors. ACG Case Rep J 2021;8:e00625. [PMID: 34258305 DOI: 10.14309/crj.0000000000000625] [Reference Citation Analysis]
23 Rastogi V, Singh D, Mazza JJ, Parajuli D, Yale SH. Flushing Disorders Associated with Gastrointestinal Symptoms: Part 1, Neuroendocrine Tumors, Mast Cell Disorders and Hyperbasophila. Clin Med Res 2018;16:16-28. [PMID: 29650525 DOI: 10.3121/cmr.2017.1379a] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]